NCR2 and Miyoshi myopathy: Finally, in another in vitro study on MM cells, the inhibitory binding of PCNA on cancer cells with NKp44 was blocked with the mAb 14-25-9, enhancing NK cell anti-tumor activity, IFN-γ production, and degranulation [98].